Derivation of exposure factors for infant lactational exposure to persistent organic pollutants (POPs)
Hep-2 cell based indirect immunofluorescence assay for antinuclear antibodies as a potential diagnosis of drug-induced autoimmunity in nonclinical toxicity testing
Safety and mutagenicity evaluation of Vigiis 101 powder made from Lactobacillus paracasei subsp. paracasei NTU 101
The toxicokinetic profile of curdione in pregnant SD rats and its transference in a placental barrier system detected by LC–MS/MS
Purification, characterization and safety assessment of the introduced cold shock protein B in DroughtGard™ maize
Lead isotope profiling in dairy calves
Mirabel: An integrated project for risk and cost/benefit analysis of peanut allergy
Corrigendum to “Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 2: Smoke chemistry and in vitro toxicological evaluation using smoking regimens reflecting human puffing behavior” [Regul. Toxicol. Pharmacol. 64 (2012) S11–S34],
Corrigendum to ‘Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 8: Nicotine Bridging – Estimating smoke constituent exposure by their relationships to both nicotine levels in mainstream cigarette smoke and in smokers’ [Regul. Toxicol. Pharmacol. 64 (2012) S85–S97],
Consumption patterns and biomarkers of exposure in cigarette smokers switched to Snus, various dissolvable tobacco products, Dual use, or tobacco abstinence
The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS)
Relationship between lethal toxicity in oral administration and injection to mice: Effect of exposure routes
The safety of a dry spearmint extract in vitro and in vivo
Magnitudes of biomarker reductions in response to controlled reductions in cigarettes smoked per day: A one-week clinical confinement study ☆
Derivation of human Biomonitoring Guidance Values for chlorpyrifos using a physiologically based pharmacokinetic and pharmacodynamic model of cholinesterase inhibition
Evaluation of aromatic amines with different purities and different solvent vehicles in the Ames test
Causes of drug shortages in the legal pharmaceutical framework
Evaluation of toxicity to triclosan in rats following 28 days of exposure to aerosol inhalation
Local tolerance and systemic toxicity of single and repeated intramuscular administrations of two different formulations of the RTS,S malaria candidate vaccine in rabbits
Introducing conformal prediction in predictive modeling for regulatory purposes. A transparent and flexible alternative to applicability domain determination
Long-term toxicity study of rAd5-hTERTC27 in SD rats and Cynomolgus monkeys by intravenous injection
(Q)SAR assessments of potentially mutagenic impurities: A regulatory perspective on the utility of expert knowledge and data submission
Utilizing relative potency factors (RPF) and threshold of toxicological concern (TTC) concepts to assess hazard and human risk assessment profiles of environmental metabolites: A case study
Estimation of the chemical-induced eye injury using a weight-of-evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): Part I: Irritation potential ☆,☆☆,☆☆☆
Estimation of the chemical-induced eye injury using a Weight-of-Evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): Part II: Corrosion potential
Assessing skin sensitization hazard in mice and men using non-animal test methods
Corrigendum to “Safety evaluation of phytase 50104 enzyme preparation (also known as VR003), expressed in Pseudomonas fluorescens , intended for increasing digestibility of phytate in monogastrics” [Regul. Toxicol. Pharmacol. 70(2) (2014) 545–554],